The Study of Relapse Predicting Model for First Episode Depression: Big Data Analysis Based on Clinical Features and Immunochemistry
试验速览
- 阶段
- 不适用
- 入组人数
- 300
- 主要终点
- HAM-D total score
研究概览
简要总结
Major depressive depression(MDD) is an severe public mental disorders. The purpose of current study is using big data analysis based on clinical features and immunochemistry to investigate and establish an relapse predict model for patients with first episode MDD.
详细描述
Major depressive depression(MDD) is an severe public mental disorders. The purpose of current study is using big data analysis based on clinical features and immunochemistry to investigate and establish an relapse predict model for patients with first episode MDD.
This study includes two steps. Step 1: Big data analysis based on the clinical features and immunochemical figures of 30000 patients with first episode MDD will be conducted to construct a relapse predict model.
Step 2: 300 patients with first episode MDD will be recruited in this step. Physicians prefer to give corresponding treatment recommendation based on the predictive factors to verify this relapse model.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age from 18 to 65 years old;
- •Han Chinese;
- •Outpatient and inpatient patients;
- •Patients met Diagnostic and Statistical Manual of Mental Disorders(DSM-IV-TR) criteria of bipolar I or II disorder, currently depressed, ascertained with the Mini International Neuropsychiatric Interview (MINI)
- •Hamilton Depression Scale(HAM-D) total score≥17, HAM-D item 1 (depressed mood) score≥2, and Young Mania Rating Scale(YMRS) total score≤10 at baseline;
- •Written informed consent was given;
- •Junior high school education and above, with enough audio-visual ability to accomplish the visits;
- •Normally resident in one country and had a residential address, able to follow-up.
排除标准
- •Bipolar disorder rapid cycling or mixed episode;
- •Experienced DSM-IV-TR axis I disorders in the 6 months prior to randomization;
- •Severe personality disorder, metal retardation, anorexia/bulimia nervosa;
- •Actively suicide ascertained by research psychiatrist or HAM-D item 3 score≥3(suicidality);
- •Female patients who were pregnant, planning to be pregnant or breast feeding;
- •Severe medical or neurological problems.
研究组 & 干预措施
Clinical features and medication
A group patients with significant high risk of clinical features and medications.
干预措施: Clinical features and medication (Other)
Psycho-social
A group patients with significant high risk of psycho-social problems.
干预措施: Psycho-social (Other)
immunology
A group patients with significant high risk of immune disturbance.
干预措施: immunology (Other)
Laboratory abnormality
A group patients with significant high risk of Laboratory abnormalities.
干预措施: Laboratory abnormality (Other)
Comorbidity
A group patients with physical or mental disorders comorbidities.
干预措施: Comorbidity (Other)
Treatment as usual
Control group.
干预措施: Treatment as usual (Other)
结局指标
主要结局
HAM-D total score
时间窗: 12 weeks
The change from baseline to end of study (EOS) in HAM-D total score
次要结局
- Time to relapse(12 months)